IL6 and diabetes mellitus: Interleukin-1β is a key regulator of inflammation both in T1DM and T2DM and has been shown to induce pancreatic β-cell apoptosis and exacerbate the systemic inflammation associated with diabetes, for instance by augmenting adipocyte TNF-α and IL-6 production (Akash et al., 2012).